Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

LYVE1 antibody (Biotin)

The Rabbit Polyclonal anti-LYVE1 antibody has been validated for FACS. It is suitable to detect LYVE1 in samples from Mouse.
Catalog No. ABIN1589714

Quick Overview for LYVE1 antibody (Biotin) (ABIN1589714)

Target

See all LYVE1 Antibodies
LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))

Reactivity

  • 77
  • 55
  • 26
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Mouse

Host

  • 85
  • 6
  • 5
  • 1
  • 1
Rabbit

Clonality

  • 82
  • 16
Polyclonal

Conjugate

  • 55
  • 8
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This LYVE1 antibody is conjugated to Biotin

Application

  • 72
  • 32
  • 28
  • 21
  • 15
  • 12
  • 10
  • 9
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)
  • Specificity

    Recombinant mouse soluble LYVE-1

    Characteristics

    Chromosomal location: 7, 7F2
    Produced from sera of rabbits immunised with highly pure recombinant mouse soluble LYVE-1 produced in insect cells. The recombinant soluble LYVE-1 consists of amino acid 24 (Ala) to 228 (Gly) and is fused to a C-terminal His-tag (6xHis). LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. The deduced amino acid sequence of LYVE-1 predicts a 322-residue type I integral membrane polypeptide 41% similar to the CD44 HA receptor with a 212-residue extracellular domain containing a single Link module the prototypic HA binding domain of the Link protein superfamily. Like CD44, the LYVE 1 molecule binds both soluble and immobilized HA. However, unlike CD44, the LYVE-1 molecule colocalizes with HA on the luminal face of the lymph vessel wall and is completely absent from blood vessels. Hence, LYVE-1 is the first lymph-specific HA receptor to be characterized and is a uniquely powerful marker for lymph vessels themselves.

    Purification

    The antibody was purified via an antigen-affinity column and then biotinylated using a standard protocol.

    Isotype

    IgG
  • Application Notes

    FACS: use 3-10 µg/mL

    Comment

    Rabbit IG Polyclonal Antibody

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.

    Buffer

    PBS, BSA (50x), 0.02 % sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Centrifuge vial prior to opening.

    Storage

    -20 °C

    Storage Comment

    The lyophilized antibody is stable at room temperature for up to 1 month. The reconstituted antibody is stable for at least two weeks at 2-8 °C. Frozen aliquots are stable for at least 6 months when stored at -20 °C.

    Expiry Date

    6 months
  • Target

    LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))

    Alternative Name

    Lyve-1

    Background

    LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. The deduced amino acid sequence of LYVE-1 predicts a 322-residue type I integral membrane polypeptide 41 % similar to the CD44 HA receptor with a 212-residue extracellular domain containing a single Link module the prototypic HA binding domain of the Link protein superfamily. Like CD44, the LYVE-1 molecule binds both soluble and immobilized HA. However, unlike CD44, the LYVE-1 molecule colocalizes with HA on the luminal face of the lymph vessel wall and is completely absent from blood vessels. Hence, LYVE-1 is the first lymph-specific HA receptor to be characterized and is a uniquely powerful marker for lymph vessels themselves.
    Synonyms: Lyve1, Xlkd1, Lyve-1, Crsbp-1, 1200012G08Rik

    NCBI Accession

    NP_444477, NM_053247

    UniProt

    Q8BHC0

    Pathways

    Glycosaminoglycan Metabolic Process
You are here:
Chat with us!